Indications
Ixiaro is indicated for active immunisation against Japanese encephalitis in adults, adolescents, children and infants aged two months and older. Ixiaro should be considered for use in individuals at risk of exposure through travel or in the course of their occupation.
Composition
- Active substance
- Japanese-encephalitis virus, inactivated (attenuated strain SA14-14-2 grown in vero cells)
- International name (INN)
- Japanese encephalitis vaccine (inactivated, adsorbed)
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Ixiaro
- ATC code
- J07BA02
- Therapeutic area
- Encephalitis, Japanese, Immunization